Select Countries

00
Select All
Clear All
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Rep
Chad
Comoros
Congo
Côte d’Ivoire
Djibouti
DRC
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Rwanda
SADR
São Tomé and Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zambia
Zimbabwe

Select Indicators

Clear All
00
Reproductive, Maternal, Neonatal and Child Health
Adolescent Fertility Rate
Births Attended by Skilled Personnel
Contraceptive Prevalence
Infant Mortality Rate
DPT3 Immunization Coverage in Children
Maternal Mortality Ratio
Neonatal Mortality Rate
Pregnant Women with 4 ANC Visits
Stunting Under 5 yrs
Under-5 Mortality Rate
Unmet Need for Family Planning
Women Who Received Post-partum Care
HIV and AIDS
Adults Tested for HIV and Know Status
HIV Knowledge (Men aged 15-24 yrs)
HIV Knowledge (Women aged 15-24 yrs)
HIV Patients Receiving Anti-retroviral Drugs
HIV Positive Pregnant Women who Receive Antiretrovirals
HIV and TB Treatment
HIV Prevalence (Females 15-24 yrs)
Pregnant Women Tested for HIV and Know Status
School Attendance of Orphans
Condom Use
Malaria and Tuberculosis
Malaria Incidence
Malaria Deaths
Pregnant Women who Received 3 Doses of IPT
Under 5s Treated with Anti-Malarial Drugs
Under 5s who Slept Under ITN
Under 5s with Fever in Last 2 Weeks Screened for Malaria
TB Case Detection Rate
TB Treatment Success Rate
Health Finance
General Gov Exp on Health as % of GGE
Out of Pocket Health Expenditure
Per Capita Public Funds for Health

Create Chart

 

 
 

Your Selection

Countries:
Indicators:
  • None selected
  • None selected

Indicator Title

Return

Indicator Information

Select Stats

Contact

Alphabetical order

Download
Print
What does it mean ?
Full Name:Proportion of adults and children living with advanced HIV infection receiving antiretroviral drugs
Full Unit:Percentage (%)
Year-range of Data:2014
Source:UNAIDS AIDSinfo
Link :http://aidsinfo.unaids.org/
Date Source Published:4th December 2015
Date Source Accessed:11th April 2016

The following countries had no data:
Comoros, Libya, Morocco, SADR, Seychelles

Alternative Data Sources

HIV Patients Receiving Anti-retroviral Drugs

What does it mean ?

This indicator refers to the percentage of children and adults currently receiving antiretroviral therapy (ART) among the number of those who are eligible to receive treatment. ART consists of the use of at least three anti-retroviral drugs that suppress the activity of retroviruses, such as HIV, in the body. Following the World Health Organization’s recommendations, adults who are considered eligible for ART are those with a CD4 count of 350 or less cells per cubic millimeter of blood. CD4 refers to the white blood cells in the body that are an important part of the immune system’s response to infections.

Why does it matter ?

This indicator shows the progress of providing anti-retroviral drugs to those living with HIV infection and eligible for them. There are an increasing number of people who are reaching the advanced stages of HIV infection. It is for this reason that the use of ART, which has been shown to reduce the number of deaths from HIV, has become more important to make available to those who need it.

How is it collected ?

Two pieces of information are needed: 1) estimated number of adults and children eligible for antiretroviral therapy (ART) and receiving the therapy and 2) estimated overall number of adults and children eligible for ART. The first is collected from facility-based ART registers and linked cross-sectional forms. The second is generated from HIV estimation models such as Spectrum. The indicator is calculated by dividing the first piece of information by the second.

Find out more about the Summary Definition and the Methodology for Collection and Calculation

Share this :

Close

Summary Definition, Methodology for Collection and Calculation

Alternative Data Sources

The data for each indicator on African Health Stats (AHS) are published by the UN agency, or UN inter-agency group, which holds responsibility for global monitoring of the indicator. This varies by indicator. Please refer to ‘Data Source’. AHS uses data from these sources because such data are internationally comparable and it is the mandate of those agencies to prepare such data and monitor progress internationally. In some cases the UN agency has made adjustments to the data in order to make national data internationally comparable, for example they may adjust national estimates to account for differences in survey design, the extent of potential underreporting, and the definition of what is being measured (eg. maternal deaths). This means that at times there may be discrepancies between national and international estimates. Individual countries may prefer to instead rely on national figures for national monitoring. For uniformity, AHS uses only international estimates of the UN agencies in data visualisations.

In 2014, the following countries communicated that they use alternative figures to monitor the indicator HIV Patients Receiving Anti-retroviral Drugs instead of the figures that appear in AHS data visualisations. The most recent alternative figure supplied by these countries, by source are: NA.

Collection Summary

Two pieces of information are needed to calculate this indicator: 1) estimated number of adults and children eligible for antiretroviral therapy (ART) and receiving the therapy and 2) estimated overall number of adults and children eligible for ART.

The first is obtained from ART registers filled in at health facilities and linked cross-sectional forms. The second is obtained using a modelling software package called Spectrum, which uses a variety of information to estimate treatment needs including surveillance data, prevalence of HIV in adults over time, average survival of those living with HIV with and without ART, average period between seroconversion, and eligibility for ART.

Using these two estimates, the indicator is calculated by dividing the number of adults and children eligible for antiretroviral therapy (ART) and receiving the therapy by overall number of adults and children eligible for ART.

For further information, download the Global AIDS Response Progress Reporting 2015: http://www.unaids.org/sites/default/files/media_asset/JC2702_GARPR2015guidelines_en.pdf

CARMMA African Union

This site is managed by the African Union's Department of Social Affairs

Language:

English

French

Keep up to date:

Twitter

Facebook